Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model

AKAR, Ebru; Oner, VEYSİ; Kucukerdonmez, Cem; AKOVA, Yonca

doi:10.3980/j.issn.2222-3959.2013.02.05

Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model

Atıf İçin Kopyala

AKAR E. E., Oner V., Kucukerdonmez C., AKOVA Y. A.

INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, cilt.6, sa.2, ss.136-140, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 6 Sayı: 2
Basım Tarihi: 2013
Doi Numarası: 10.3980/j.issn.2222-3959.2013.02.05
Dergi Adı: INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.136-140
Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

AIM: To compare the efficacies of subconjunctival bevacizumab, ranibizumab, and pegaptanib sodium injections for the inhibition of corneal neovascularization in an experimental rat model.